Home > Boards > US OTC > Medical - Healthcare > Progressive Care, Inc. (RXMD)


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
ndww42 Member Profile
Followed By 43
Posts 2,416
Boards Moderated 1
Alias Born 10/13/14
160x600 placeholder
Progressive Care Releases Audited 2017 Annual Report InvestorsHub NewsWire - 3/22/2018 8:00:00 AM
Progressive Care to Present at The Wall Street Investor Forum 26th Annual Investor Conference InvestorsHub NewsWire - 3/16/2018 1:56:39 PM
Progressive Care Reports 18% Increase in Year over Year Prescriptions Filled During February 2018 InvestorsHub NewsWire - 3/16/2018 1:51:59 PM
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share InvestorsHub NewsWire - 3/9/2018 9:25:14 AM
StereoVision (SVSN) $420 million in Sales from $1,000 Acre Hemp Farm Lease InvestorsHub NewsWire - 3/6/2018 6:47:36 AM
Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County InvestorsHub NewsWire - 3/2/2018 9:40:34 AM
Progressive Care to Accept Bitcoin for its Pharmacy Unit InvestorsHub NewsWire - 2/15/2018 10:27:52 AM
Vita Mobile (OTC Pink: VMSI) Develops Artificial Intelligence to work with Facebook, Twitter and Instagram InvestorsHub NewsWire - 2/15/2018 7:00:45 AM
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018 InvestorsHub NewsWire - 2/13/2018 9:03:01 AM
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions InvestorsHub NewsWire - 1/25/2018 8:00:00 AM
Progressive Care Ends Agreement with Boustead Securities InvestorsHub NewsWire - 1/23/2018 11:17:39 AM
Progressive Care Releases Open Letter to Shareholders InvestorsHub NewsWire - 1/16/2018 11:54:30 AM
Progressive Care Continues to Break Records with Over $20 Million in Sales InvestorsHub NewsWire - 1/10/2018 12:11:11 PM
Progressive Care Reports Strong November Sales to Begin End of Year Rally InvestorsHub NewsWire - 12/15/2017 9:48:16 AM
Progressive Care Announces Uplist to OTCQB InvestorsHub NewsWire - 12/4/2017 11:16:25 AM
ANCE - RESTANCE Highlights Hugh Hefner and Playboy's Contribution To Fighting AIDS and Advocating Gay Rights InvestorsHub NewsWire - 12/1/2017 11:52:28 AM
Progressive Care Reports Stellar Third Quarter Results InvestorsHub NewsWire - 11/15/2017 8:30:00 AM
Progressive Care Announces Third Quarter Conference Call and Webcast with Investors on November 14, 2017 InvestorsHub NewsWire - 11/13/2017 9:34:28 AM
Progressive Care Pays Down Chicago Venture Partners Note in Second Installment InvestorsHub NewsWire - 10/26/2017 10:40:37 AM
Progressive Care Reports $1.5 Million Revenues on 17,000 Prescriptions in September InvestorsHub NewsWire - 10/13/2017 9:34:27 AM
Progressive Care Submits Application for OTCQB Listing InvestorsHub NewsWire - 10/5/2017 8:30:00 AM
Progressive Care Appoints Oleg Firer as an Independent Board Member MIAMI, FL (Marketwired September 25 2017) - Progressive InvestorsHub NewsWire - 9/25/2017 9:16:38 AM
Progressive Care Reports $1.8 Million Revenues on 20,000 Prescriptions in August InvestorsHub NewsWire - 9/19/2017 8:30:00 AM
ndww42   Sunday, 03/04/18 09:27:40 AM
Re: None
Post # of 79425 

February NET revenues: Week of March 12th or 19th or sooner - should be record net revenues again with possibly our second 2M+ month.

Acquisition details: With the latest announcement of the company's intent to purchase a pharmacy in Palm Beach County, we will see additional details around this purchase and what it means on the revenue side.

Audited Annual Report: Report is due 3/31 and will be the second audited year. Having two years of audited fins is the gold standard for institutional monies to flow in.

Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report.

March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.

Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams

Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.

Institutional stock coverage: Shital has made it clear that she'd like to have coverage of the stock by institutional analysts. We are seeing more and more signs of this and will hear more about it soon IMO.

Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.

CBD / MJ / HEMP: One of the latest major developments. Additional news about CBD and MJ will most likely be coming out in the next couple of months. They already stated they will have in-house compounding and R&D! This will boost sales big time as customers would like to see alternatives to addictive pain pills.

Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.

Investor conferences to attract institutional investors: They will most likely PR these events over the coming months.

New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners

New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.

Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.

Traditional financing: Expect news of traditional financing over the coming year.

Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.

More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.

Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales

Expansion / M&A: We should be seeing additional PBM contracts related to their recent acquisition. I also believe we will hear more about additional acquisitions and other partnerships.

NASDAQ uplisting: With traditional financing, 2 locations and a much higher PPS, I expect to start to hear more about the company's plan to uplist to NASDAQ.

RXMD - King of the OTC

Best of the Best!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist